Amygdala Neurosciences, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2015-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.amygns.com
A Study to Evaluate the Safety of the Coadministration of ANS-6637 and Ethanol
Phase 1
Completed
- Conditions
- Healthy Volunteers
- Interventions
- Drug: ANS-6637 Oral TabletDrug: Placebo Oral Tablet
- First Posted Date
- 2017-06-29
- Last Posted Date
- 2018-01-17
- Lead Sponsor
- Amygdala Neurosciences, Inc.
- Target Recruit Count
- 48
- Registration Number
- NCT03203499
- Locations
- 🇺🇸
Vince and Associates, Overland Park, Kansas, United States
© Copyright 2025. All Rights Reserved by MedPath